On the other hand, the static nature of the Dsg3-reactive B cell repertoire that persists over time and causes disease relapse in PV patients suggests that Dsg3 ectodomain could be an effective target for PV therapy (20, 271, 275–278). Here, DSG3 is linked to acquired polycythemia vera.